ASAnton Smirnov

Anton Smirnov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anton Smirnov has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial intelligence in developing doctoral students' research competencies

    by Iryna Оliinyk, Olena Bulavina, Tetiana Romanenko, Anzhelika Tatarnikova, Anton Smirnov

    The study deals with the topical issue of introducing artificial intelligence (AI) into the students’ professional training at the third educational and research level of higher education. The aim of the study is to empirically verify the AI role in building the research competence of future doctors of philosophy (PhDs). The research employed the following methods: monitoring, quantitative, qualitative, comparative data analysis, modelling. The study involved monitoring the development of the students’ research competence of the third educational and research level of higher education according to substantive, design, procedural, optional, communicative components. The method of using AI in building the research competence of PhD students was developed and tested. The level of research competence increased during the implementation of the method of using AI. So, the growth was the following: substantive – by 7.5%, design – by 10%, procedural – by 8.4%, optional – by 11.4%, and communicative – by 8.5% components. The results of the study can be used in the educational process of higher education institutions (HEIs) to create the content of the training of applicants. The prospect of research is the development of recommendations regarding the use of AI tools in the development of their research skills.


  • Could the Propionic Acid Treatment in Combination with Metformin be Safe for the Small Intestine of Diabetic Rats?

    by Larysa Natrus, Olha Lisakovska, Anton Smirnov, Yuliia Osadchuk, Serhyi Savosko, Yuliia Klys

    Background: Effects of propionic acid (PA) on the cellular and molecular processes in the small intestine under type 2 diabetes mellitus (T2DM)-induced endoplasmic reticulum (ER) stress remain incompletely studied. Objectives: The aim of the study was to assess the state of unfolded protein response (UPR) system in the small intestine of diabetic rats and to explore PA’s influence on metformin treatment. Methods: Male Wistar rats were divided into 1) control and 2) T2DM groups, and groups receiving (14 days, orally) 3) metformin (60 mg/kg), 4) PA (60 mg/kg), and 5) PA+metformin. Western blotting, RT-PCR, and transmission electron microscopy were performed. Results: We found that T2DM induced elevation of ER intermembrane space and UPR overactivation based on increased GRP78, ATF6 and PERK levels in small intestine. Metformin treatment led to a further UPR activation. PA supplementation partially restored enterocytes functioning via normalization of ATF6 and PERK content, while IRE1 level reached the maximum value, compared to all groups. The most pronounced effect of adaptation to the T2DMinduced ER stress was observed after combined metformin and PA action. In particular, decreased ER intermembrane space in enterocytes was detected compared to separate metformin and PA administration, which was accompanied by restored GRP78, PERK and IRE1 levels. Conclusion: Our study proves the safety of additional therapy with propionic acid in combination with metformin for the functional state of small intestine. Due to its ability to modulate UPR signaling, PA may be considered a safe and perspective candidate for supportive therapy in T2DM, especially for neuroprotection.


  • The Role of Artificial Intelligence in Building the Research Competence of Future Doctors of Philosophy

    by Iryna Oliinyk, Olena Bulavina, Tetiana Romanenko, Anzhelika Tatarnikova, Anton Smirnov

  • Open Access

    Use of electronic search systems in the investigation of corruption crimes in Ukraine: opportunities and challenges for human rights

    by Oleksandr Babikov, Anton Smirnov, Maryna Chernysh, Serhii Syrovatka, Ihor Pylypenko


  • Open Access

    INFORMATIVE BIOMARKERS IN THE STUDY OF THE PROCESSES OF PROLIFERATION, APOPTOSIS AND AUTOPHAGY IN THE TISSUES OF THE DIGESTIVE SYSTEM IN EXPERIMENTAL METABOLIC SYNDROME. Review

    by A.S. Smirnov

    Diabetes mellitus is a widespread disease in the world. Diabetes mellitus type 2 is more and more common in younger people and has many complications. In particular, diabetes causes complications in the gastrointestinal tract. A metabolic syndrome is a state in which metabolic disorders occur. A certain role in the development of metabolic syndrome belongs to the gastrointestinal tract. On the other hand, the presence of metabolic syndrome is a significant risk factor for diseases of the gastrointestinal tract. The development of complications of diabetes and metabolic syndrome is known to be associated with disorders of cell proliferation, apoptosis, and autophagy. Immunohistochemical methods are widely used in scientific research to evaluate the state of cell proliferation, apoptosis and autophagy in the tissues of the digestive system, in particular in the liver, stomach, pancreas, small intestine and colon. Immunohistological methods provide valuable data on the nature of changes in the processes of cell proliferation, apoptosis and autophagy in the tissues of the digestive system under conditions of metabolic disorders, in particular in diabetes and in metabolic syndrome. Therefore, the use of immunohistochemical methods to determine the proliferative activity by the expression of nuclear antigen Ki-67 and by the expression of nuclear antigen of proliferating cells PCNA , assessment of the state of apoptosis processes by expression of protein Bcl-2 and protein BAX, as well as to determine the nature of the processes of autopsy by expression of Beclin-1 (BECN1) in the tissues of the digestive system in experimental metabolic syndrome and diabetes mellitus type 2 is quite reasonable.

  • Open Access

    THE PATHOGENETIC RATIONALE THE WAYS OF EXPERIMENTAL TYPE 2 DIABETES MELLITUS MODELING

    by L.V. Natrus, Yu.S. Osadchuk, D.O. Labudzinskyi, Yu.B. Chaikovsky, A.S. Smirnov

    Relevance. When modeling experimental type 2 diabetes mellitus (T2DM), various schools and research groups receive significant variability in tissue changes, which is difficult to compare and extrapolate as a specific pathogenic or pharmacological effect. The lack of standard operating procedures agreed upon in the scientific community greatly complicates the interpretation of the result. Therefore, the creation of a uniquely pathogenetic animal model of CD2 in animals is an urgent task. Objective. Determination of the complex of exogenous effects for the most efficient reproduction of the experimental model of T2DM in rats and the pathogenetic justification of the changes in the body to study the central mechanisms of homeostasis regulation and their pharmacological correction. Materials and methods. T2DM was model in rats by feeding a high-fat diet (HFD) with additional streptozotocin induction. The model was evaluated by anthropometric measurements, studies of biochemical parameters, an insulin tolerance test, analysis of the spectrum of fatty acids in the composition of tissues. Statistical data processing was performed with using the IBM SPSS Statistics 23. Results. The obtained data were compared with our studies of the lipid metabolism of patients with varying degrees of diabetic retinopathy on the background of T2DM and analysis of the information content of biochemical markers to assess lipid metabolic disturbances on the background of hyperglycemia in patients. It was found that the simulation in rats of experimental T2DM by a food load of HFD (45%) + fructose 20% for 3 months followed by a single induction of streptozotocin (25 mg/kg) causes changes in lipid and carbohydrate metabolism in animals similar changes which are in the human with a diagnosed long-term diabetes and the development of microvascular complications. Conclusion. We determined the optimal combination of effects and developed a consistent experimental load scheme that allows us to obtain a symptom model of type 2 diabetes in an animal experiment. Using the diagnostic algorithm, which includes physiological and laboratory methods, the degree of damage to organs and systems was determined, a comparison was made with the level of metabolic disorders in patients with T2DM and people without diabetes. The given model is a pathogenetically grounded approach for further study of the central mechanisms of homeostasis regulation and their pharmacological correction